Account
Inquiry
Introducing our innovative Disposable Syringe Pen, a premier solution engineered for advanced weight management, diabetes care, and critical research applications—including support for retatrutide trial sign up initiatives. This state - of - the - art device is meticulously designed to meet the precise dosing needs of medications like retatrutide, liraglutide, insulin, and other essential therapeutics, making it an ideal choice for those participating in retatrutide trial sign up programs. With a 3ml filling capacity, it enables adjustable dosing from a minimum of 0.01ml to a maximum of 0.6ml, ensuring accuracy in every injection—a crucial factor for retatrutide trial sign up participants who require consistent and reliable dosing.
The syringe pen features a user - friendly push mechanism that delivers smooth and exact injections. Its compatibility with a wide range of medications, including retatrutide (for research use only), liraglutide, insulin, exenatide, growth hormone, teriparatide, and GLP - 1 analogs, makes it a versatile tool for various treatment and research regimens. This versatility is particularly valuable for retatrutide trial sign up projects, where the ability to administer different medications with precision is essential.
From a regulatory and safety perspective, this device holds a China Class II medical device registration certificate, which is a testament to its high - level credibility and safety standards. This certification provides peace of mind to healthcare professionals and retatrutide trial sign up participants alike, knowing that the device meets rigorous quality requirements. Additionally, it has successfully completed the CDE packaging record, further highlighting its adherence to compliance standards in the medical and research fields.
When it comes to its applications, the Disposable Syringe Pen is ideally suited for effective diabetes management, weight loss aid, and medical aesthetics. In the context of retatrutide trial sign up, it serves as a reliable injection tool for administering retatrutide (供研究使用，不提供个人使用) during clinical trials. Its auto - injection mode, combined with a single injection time of 6 seconds or less, ensures a quick and comfortable injection experience. After injection, both visual and auditory feedback confirm the completion of the injection, reducing the risk of dosing errors—an important consideration for retatrutide trial sign up participants who need to follow strict dosing protocols.
The device is equipped with a 3ml cartridge (inner diameter φ9.7mm) and supports needle diameters of 31G/32G or smaller, minimizing discomfort during injection. Its dimensions of 17mm (pen dimensions) make it compact and easy to handle, whether in a clinical setting or for retatrutide trial sign up participants using it at home as part of the trial protocol.
We are a factory - direct supplier, offering wholesale, customized, and supply services for this Disposable Syringe Pen. Our customization options allow us to tailor the product to meet the specific needs of different retatrutide trial sign up programs or other medical and research applications. Whether you need a specific labeling option, color, or other custom features, we can accommodate your requirements to ensure the syringe pen aligns with your project's objectives.
Here are some images of our Disposable Syringe Pen, showcasing its design and features:
